Bausch + Lomb: FDA 510(k) clearances across all its applicant names

FDA lists 290 510(k) clearances, 34 PMA and 0 De Novo decisions across the 7 applicant names Caduvo groups under Bausch + Lomb, first 1976, latest 2026. Median 510(k) review time across these names: 80 days. Since 2017 the median was 97 days, against 107 days for all cleared 510(k)s in the same product codes. Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.

510(k) clearances per year

YearClearancesMedian review days
20126190
20137135
20146123
2015454
20163147
2017862
2018351
2019278
20203166
20213177
20221106
20232298
20243186
20250—
2026356

The 7 FDA applicant names in this group

Applicant name510(k) clearancesPMADe NovoYears
Bausch & Lomb, Inc.1383201977–2026
Storz Instrument Co.101001976–1998
Chiron Vision Corp.34001980–1997
Technolas Perfect Vision GmbH10101999–2020
Bausch & Lomb Pharmaceutical, Inc.6001988–1990
Bausch & Lomb Healthcare and Optics Worldwide1001995–1995
Bausch & Lomb Surgical, Inc.010—

Review time against the same product codes

Since 2017, 510(k)s cleared under these names took a median 97 days from FDA receipt to decision. All cleared 510(k)s in the same product codes over the same years took a median 107 days.

Top product codes

Product codeDeviceSubmissions510(k) clearances
HQCUnit, Phacofragmentation4747
LPLLenses, Soft Contact, Daily Wear2121
LPNAccessories, Soft Lens Products2020
HQLIntraocular Lens170
HQEInstrument, Vitreous Aspiration And Cutting, Ac-Powered1616
MSSFolders And Injectors, Intraocular Lens (Iol)1313
HNOKeratome, Ac-Powered99
OOEOphthalmic Femtosecond Laser99
HQDLens, Contact (Other Material) - Daily88
MOECollagen Corneal Shield88

Plus 90 more product codes.

Review panels

Most recent Bausch + Lomb 510(k) clearances

510(k)DeviceApplicant nameProduct codeDecision dateReview days
K262941Bausch + Lomb Multifocal for Astigmatism (kalifilcon A) One-Day Soft (hydrophilic) Contact LensBausch & Lomb, Inc.LPL2026-10-1656
K261264Stellaris Elite™ vision enhancement system; Posterior and Combined Procedure Pack(s): 23 ga. Posterior Elite™ Pack (SE5423); 23 ga. Bi-Blade™ Vitreous Cutter Posterior Stellaris Elite™ Pack (SE5423B); 25 ga. Posterior Elite™ Pack (SE5425); 25 ga. Bi-Blade™ Vitreous Cutter Posterior Stellaris Elite™ Pack (SE5425B); 27 ga. Bi-Blade™ Vitreous Cutter Posterior Stellaris Elite™ Pack (SE5427B); 23 ga. Bi-Blade™+ Vitreous Cutter Posterior Stellaris Elite™ Pack (SE5423BB+); 25 ga. Bi-Blade™+Bausch & Lomb, Inc.HQC2026-05-1529
K252052Stellaris Elite™ vision enhancement system (BL11145, BL14455, BL15455, SE14565, SE15565, SE14565E, SE15565E)Bausch & Lomb, Inc.HQC2026-03-25267
K242389EyeGility™ Inserter for Preloaded enVista IOLsBausch & Lomb, Inc.MSS2024-10-1059
K240169Stellaris Elite vision enhancement system (BL11145, BL14455, BL15455)Bausch & Lomb, Inc.HQC2024-07-26186
K232084Stellaris Elite vision enhancement systemBausch & Lomb, Inc.HQC2024-02-26228
K230954Samfilcon B Custom Contact LensBausch & Lomb, Inc.LPL2023-11-17227
K220613Bausch + Lomb (kalifilcon A) Soft (hydrophilic) Contact Lens, Bausch + Lomb (kalifilcon A) Soft (hydrophilic) Contact Lens for Astigmatism, and, Bausch + Lomb (kalifilcon A) Soft (hydrophilic) Contact Lens for PresbyopiaBausch & Lomb, Inc.LPL2023-03-08370
K222541Bausch + Lomb Preservative Free Lubricating and Rewetting DropsBausch & Lomb, Inc.LPN2022-12-06106
K211786Independent Corneal Viewing Chamber (IVC-21)Bausch & Lomb, Inc.LYX2021-12-03177

280 earlier clearances. See the full list in Caduvo.

PMA and De Novo decisions

NumberPathwayDeviceDecision date
P240005PMAenVista Envy™ hydrophobic acrylic intraocular lens (IOL), enVista Envy™ toric hydrophobic acrylic intraocular lens (IOL)2024-10-10
P170035PMABausch + Lomb Ultra (samfilcon A) Contact Lenses2018-04-30
P080021PMAXACT FOLDABLE HYDROPHOBIC ACRYLIC ULTRAVIOLET LIGHT-ABSORBING POSTERIOR CHAMBER INTRAOCULAR LENS (IOL)2009-02-02
P060022PMAAKREOS POSTERIOR CHAMBER INTRAOCULAR LENS,MODEL ADAPT2008-09-05
P010062PMAEUCLID SYSTEMS ORTHOKERATOLOGY (OPRIFOCON A) CONTACT LENS FOR OVERNIGHT WEAR2004-06-07

Recalls

93 product recalls in 37 recall events under these names; 3 initiated in the last five years.

10 product recalls in 6 recall events filed under other recalling-firm names cite a 510(k) or PMA held under these applicant names; 0 initiated in the last five years. Most often: Anika Therapeutics (4), Alden Optical (2), Bausch & Lomb Inc Irb (2).

These recall records list the clearance number, so the device was cleared under this name. The recalling firm may be the same company under another spelling, a company that acquired the product line, a relabeler or a contract manufacturer. They are not added to the count above.

Recalling firms are matched to the applicant names above by name only, so recalls filed under other names are not counted. A recall count says nothing about how safe one company's devices are compared with another's.

Device clinical trials

ClinicalTrials.gov lists 109 device studies (4 active or recruiting) with an industry lead sponsor under the 3 sponsor names below. Most recent:

Lead sponsor name on ClinicalTrials.govDevice studies
Bausch & Lomb Incorporated96
Technolas Perfect Vision GmbH11
Bausch & Lomb GmbH2

Sponsor names are matched to the applicant names above by name, with punctuation and legal suffixes removed, plus sponsor names reviewed for this group. Studies listed under other sponsor names are not counted.

Parent company SEC filings

Bausch & Lomb Corp (BLCO): EDGAR filings, CIK 1860742. The parent's SEC registrant is entered by hand for this group, not matched by name.

How this group is built

Groups are curated by Caduvo from public sources listed below; FDA does not group applicants. Counts include filings made before an acquisition, and can include older filings by a business that was later sold when FDA records them under the same applicant name; see the notes on this page.

Storz Instrument Co (1986, ophthalmic surgery; unrelated to KARL STORZ), Chiron Vision (1997), Technolas Perfect Vision (2013). Includes filings made before each acquisition.

Sources

Frequently asked questions

How many FDA 510(k) clearances are listed across Bausch + Lomb's applicant names?

FDA lists 290 510(k) clearances, 34 PMA and 0 De Novo decisions across the 7 applicant names Caduvo groups under Bausch + Lomb, first 1976, latest 2026. FDA records each applicant name separately; Caduvo adds up the names listed on this page.

Which FDA applicant names does Bausch + Lomb file under?

The names with the most 510(k) clearances in this group are Bausch & Lomb, Inc. (138); Storz Instrument Co. (101); Chiron Vision Corp. (34); Technolas Perfect Vision GmbH (10); Bausch & Lomb Pharmaceutical, Inc. (6). The full list of 7 names is on this page.

How long does FDA take to clear Bausch + Lomb 510(k)s?

The median time from FDA receipt to decision across 510(k)s cleared under these names is 80 days. Since 2017 the median was 97 days, against 107 days for all cleared 510(k)s in the same product codes.

Does the Bausch + Lomb count include acquired companies?

Yes. A group includes filings an acquired business made under its own name, including before the acquisition. Businesses that were sold are left out, and names whose ownership is unclear are not included. FDA does not group applicants; the sources for each grouping are listed on this page.

How many device clinical trials does Bausch + Lomb sponsor?

ClinicalTrials.gov lists 109 device studies (4 active or recruiting) with an industry lead sponsor under 3 sponsor names Caduvo groups under Bausch + Lomb. ClinicalTrials.gov names the sponsor on each study; Caduvo adds up the names listed on this page.

Next steps

Compiled by Caduvo from public U.S. government records. Counts cover filings under the applicant names shown on this page only. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA or any other agency, or by the companies named. Not regulatory advice. Report an error in this grouping or data. Data and corrections policy.

All parent companies · FDA device companies by applicant name · FDA product code lookup